Search Results68 results found
CSL Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.
CSL Seqirus employs both egg and cell-based manufacturing systems to ensure the availability of our influenza vaccines. Learn more about our optimised technology.
Understand our aim to develop the next generation of influenza vaccines and how we're working to unite product platforms across the globe.
CSL Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.
CSL Seqirus stands with our partners on the front line of public health. We are the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more.
ESWI and CSL Seqirus look to award a third young scientist tackling influenza head on.
We produce antivenoms for Australia's most dangerous creatures and Q fever vaccines to protect people working with livestock. Learn about these unique products.
A word so ubiquitous in 2021 that Merriam-Webster had to re-define it.
We are committed to ensuring early and reliable supply of influenza vaccines using both egg and cell-based manufacturing technologies.
CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world